High-Potential Canadian Cannabis Stocks for Traders This Week
The U.S. cannabis industry remains a high-growth sector, valued at over $34 billion in 2024. Experts project it could reach $57 billion by 2030. Despite short-term volatility, marijuana penny stocks continue to attract attention from risk-tolerant investors. This week, traders are watching these low-priced stocks for potential breakouts. Many of these companies operate in emerging markets or hold licenses in high-demand states. Recently, a major Senate committee advanced a bill to expand cannabis banking access. This renewed optimism has sparked fresh momentum in the sector. As legalization efforts progress, smaller cannabis firms could benefit first from sudden volume spikes.
However, traders must approach these stocks with caution. Because of their low price, marijuana penny stocks often experience high volatility. Therefore, technical analysis is essential. Traders should focus on volume, trend strength, and price support levels. Proper risk management is also key. It’s important to size positions carefully and set clear stop-loss levels. This helps avoid emotional trading and large losses.
As the cannabis sector continues to evolve, Canadian producers are finding strategic ways to penetrate the U.S. market. Although federal legalization in the U.S. remains uncertain, these Canadian companies are positioning themselves for long-term growth. In August 2025, three Canadian cannabis stocks stand out for their U.S. expansion and evolving financial performance. These include Tilray Brands Inc. (TLRY), Canopy Growth Corporation (CGC), and Village Farms International Inc. (VFF). Each offers a unique approach to market penetration, profitability, and investor value.
[Read More] 3 Ancillary Marijuana Stocks for Long-Term 2025 Investing
Top 3 Canadian Cannabis Stocks to Watch in August 2025
- Tilray Brands Inc. (NASDAQ: TLRY)
- Canopy Growth Corporation (NASDAQ: CGC)
- Village Farms International Inc. (NASDAQ: VFF)
Tilray Brands Inc. (TLRY)
Tilray is a diversified cannabis and consumer packaged goods company with a growing U.S. footprint. Although headquartered in Canada, Tilray operates its U.S. business through its alcohol and wellness brands. The company owns several craft breweries and has expanded its reach into cannabis-infused beverages. These products are distributed in over 1,000 U.S. stores. Additionally, Tilray’s hemp-based brand, Manitoba Harvest, is sold in more than 13,000 retail outlets across the country.
While Tilray doesn’t operate traditional cannabis dispensaries in the U.S., its products are widely distributed through retail channels. The company’s U.S. strategy emphasizes beverage and wellness markets, using existing infrastructure to scale. This model allows Tilray to build strong brand recognition without needing direct dispensary ownership. Over time, this could prove to be a more efficient method of entering the U.S. cannabis space, especially ahead of future regulatory changes.
Financial Overview
Tilray recently reported quarterly net revenue of $211 million, reflecting a 9% year-over-year increase. Gross profit climbed 29% to $61 million, while the overall gross margin improved to 29%. Beverage alcohol sales led the growth, rising 36% to $63 million. Margins in that segment improved to 40%, showing Tilray’s ability to scale its consumer brands.
Cannabis revenue held steady at $66 million, and cannabis gross margin rose to 35%. The company’s adjusted net loss narrowed to just $2 million, approaching break-even status. Tilray also posted $9 million in adjusted EBITDA. Though slightly lower than last year, the figure remained strong given restructuring in its product portfolio. Overall, Tilray’s balanced strategy of combining cannabis with beverages and wellness continues to support solid financial performance in 2025.
[Read More] Top Marijuana Stocks to Watch This Week: August 2025 Watchlist
Canopy Growth Corporation (CGC)
Canopy Growth is a leading Canadian cannabis company focused on branding and distribution. Its U.S. efforts are spearheaded by Canopy USA, a platform designed to house various THC brands. Rather than building dispensaries, Canopy is creating a network of recognizable cannabis products through licensing and partnerships. These brands span multiple cannabis categories, including flower, edibles, and vape products.
Canopy no longer operates brick-and-mortar stores in Canada or the U.S., having sold its retail assets to streamline operations. In the U.S., the company focuses on expanding its market share through brand equity and indirect retail placement. This asset-light model allows Canopy to scale more efficiently and avoid regulatory risks tied to direct ownership of U.S. dispensaries. While it doesn’t report the number of stores carrying its products, its multi-state presence continues to grow through indirect distribution.
Financial Overview
Canopy reported a 9% year-over-year decline in revenue, though adjusted for divestitures, core revenue grew by 3%. The company’s consolidated gross margin rose to 35%, driven by cost controls and a shift toward higher-margin medical cannabis. This marks a notable improvement from previous quarters, as the company continues to reduce operating expenses and focus on profitability.
Its international cannabis revenue dropped due to lower sales in Europe and Australia, along with the restructuring of its U.S. CBD business. Despite these declines, Canopy is focused on long-term cost optimization. Analysts expect the company to report a moderate loss in upcoming quarters. However, the improving margins indicate operational efficiency and a more disciplined approach. Canopy remains in a transition phase but is laying the groundwork for sustainable growth once broader U.S. legalization occurs.
[Read More] 3 Marijuana Stocks For Speculative Buyers To Consider
Village Farms International Inc. (VFF)
Village Farms International is a Canadian greenhouse grower with roots in produce cultivation. Over the past few years, the company has shifted focus toward cannabis. Unlike other companies that build retail networks, Village Farms supplies cannabis products to retailers and processors across the U.S.
Village Farms doesn’t operate its own dispensaries. Instead, it leverages large-scale greenhouses to produce cannabis efficiently and sustainably. Its U.S. operations focus on supplying high-quality cannabis to licensed partners. This business-to-business model minimizes retail overhead and maximizes supply chain control. The company’s long history in greenhouse agriculture gives it a competitive advantage in scalability and cost management. While it lacks direct storefronts, its cannabis products reach dispensary shelves through strategic partners across several states.
Financial Overview
Village Farms reported quarterly revenue of $77.07 million, slightly below expectations. Earnings per share came in at a loss of $0.06, also missing analyst estimates. However, on a trailing twelve-month basis, revenue grew over 12% year-over-year, demonstrating consistent top-line growth.
Although the company is still operating at a net loss, it has made efforts to improve its financial position. Investors are eagerly awaiting Q2 2025 results, scheduled for release this month. The company is expected to provide updates on margin improvements and cost controls. Village Farms continues to invest in operational efficiency, aiming to reduce production costs and boost profitability. Despite short-term headwinds, the company’s infrastructure and production model position it well for future market expansion.
[Read More] These Marijuana Stocks Could See Better Market Action
Canadian Penny Pot Stocks to Watch as U.S. Legalization Accelerates
As August 2025 unfolds, Canadian cannabis companies continue to adapt to evolving market conditions. Tilray leads with diversified consumer brands and widespread U.S. retail reach. Canopy Growth leans on branding and cost efficiency, awaiting federal reform. Village Farms supports the market through cultivation and wholesale supply, aiming for long-term profitability.
Each of these companies takes a different approach to U.S. expansion. However, all are preparing for the next phase of growth in North America’s cannabis market. Investors should keep a close watch on earnings, regulatory updates, and strategic partnerships in the months ahead.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
